You have requested to receive a Daily Digest e-mail from U.S. Food & Drug Administration (FDA).
Message: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 30 Jan 2008 05:49:04 -0600 (CST)
Subject: CDRH New Update
FDA Home Page | CDRH Home Page | Search | A-Z Index | ||
Date: January 30, 2008 |
The following new items were added to the CDRH web pages on January 29, 2008. Previous CDRH New Items can be found on the CDRHNew Page.
Guidance for Industry and FDA Staff: Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices |
Message: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 30 Jan 2008 08:15:20 -0600 (CST)
Subject: FDA Warning Letters Update
You are subscribed to FDA Warning Letters for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
Message: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 30 Jan 2008 08:49:52 -0600 (CST)
Subject: Medical Device Recalls: AM2 PAT Inc. Pre-Filled Heparin Lock Flush Syringes and Normal Saline IV Flush Syringes
You are subscribed to Medical Device Recalls for U.S. Food & Drug Administration (FDA). Information about the AM2 PAT Inc. Pre-Filled Heparin Lock Flush Syringes and
Message: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 30 Jan 2008 14:05:47 -0600 (CST)
Subject: Nationwide Recall of NuCel Labs Eye Drops and Eye/Ear Wash Products (Jan. 29)
Nationwide Recall of NuCel Labs Eye Drops and Eye/Ear Wash Products (Jan. 29)
Wed, 30 Jan 2008 12:30:00 -0600
NuCel Labs of Idaho Falls, Idaho announced today that it is conducting a voluntary nationwide recall of all Eye Drops and Eye/Ear Wash. This recall follows an FDA inspection in which product testing indicated that there was bacteria and particulate matter in the product deeming these products non-sterile. Non-sterile eye drops pose an unacceptable risk of causing eye infections, which in rare cases could lead to blindness.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
No comments:
Post a Comment